Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.
Related Posts
08|16|21
Inside EVERSANA INTOUCH’s AI-Focused Ad Campaign
Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.
08|16|21
Can a Celebrity Influencer Work for Your Brand?
Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.
08|16|21
OpenAI’s New o1 Series Models’ Focus on “Reasoning” and What It Could Mean to Lifesciences Brands and Marketers
Intouch VP of Strategic Planning, Jeff Greene weighs in on what changes we might see in marketing strategies as biosimilar marketers look to compete with biologics.